Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD8+ T Cell Expression in Lung Cancer

被引：0
|
作者：
Jin, Yasuto
Matsubara, Osamu
Yamanaka, Kazuki
Mark, Eugene
机构：
[1] Kyosai Hosp, Hiratsuka, Kanagawa, Japan
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1935
引用
收藏
页码：481A / 481A
页数：1
相关论文
共 50 条
  • [1] Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD8+ T Cell Expression in Lung Cancer
    Jin, Yasuto
    Matsubara, Osamu
    Yamanaka, Kazuki
    Mark, Eugene
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 481A - 481A
  • [2] Intratumoral programmed cell death-ligand 1 (PD-L1) and Intratumoral CD8+T cell Expression in Lung Cancer
    Jin, Yasuto
    Yamauchi, Shuta
    Shimada, Hiroyuki
    Matsubara, Osamu
    [J]. CANCER SCIENCE, 2018, 109 : 1099 - 1099
  • [3] Expression of intratumoral programmed cell death-ligand 1 (PD-L1) and intratumoral CD8+T cell and FOXP3+T cell in lung cancer
    Jin, Yasuto
    Imase, Reina
    Shimada, Hiroyuki
    Yamauchi, Shuta
    Matsubara, Osamu
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 735 - 735
  • [4] Expression of intratumoral programmed cell death-ligand 1 (PD-L1) and intratumoral CD8+T cell and FOXP3+T cell in lung cancer
    Jin, Yasuto
    Imase, Reina
    Shimada, Hiroyuki
    Yamauchi, Shuta
    Matsubara, Osamu
    [J]. MODERN PATHOLOGY, 2018, 31 : 735 - 735
  • [5] Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer
    Jin, Y.
    Shimada, H.
    Yamauchi, S.
    Inase, N.
    Matsubara, O.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S731 - S731
  • [6] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
    Govindarajan, Rangaswamy
    Gujja, Swetha
    Siegel, Eric R.
    Batra, Anu
    Saeed, Anwaar
    Lai, Keith
    James, Jennifer D.
    Fogel, Bradley J.
    Williamson, Stephen
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 638 - 642
  • [7] Expression of intratumoral PD-L1 and intratumoral CD4+T cell, CD8+T cell, and FOXP3+T cell in lung cancer
    Shimada, Hiroyuki
    Yamauchi, Shuta
    Jin, Yasuto
    [J]. CANCER SCIENCE, 2018, 109 : 1410 - 1410
  • [8] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    Abbas, M.
    Steffens, S.
    Bellut, M.
    Eggers, H.
    Grosshennig, A.
    Becker, J. U.
    Wegener, G.
    Schrader, A. J.
    Gruenwald, V.
    Ivanyi, P.
    [J]. MEDICAL ONCOLOGY, 2016, 33 (07)
  • [9] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    M. Abbas
    S. Steffens
    M. Bellut
    H. Eggers
    A. Großhennig
    J. U. Becker
    G. Wegener
    A. J. Schrader
    V. Grünwald
    P. Ivanyi
    [J]. Medical Oncology, 2016, 33
  • [10] Intratumoral Heterogeneity of Programmed Cell Death Ligand-1 (PD-L1) Expression in Lung Cancers - Assessment by Spiral Array
    Nakamura, Sayuri
    Hayashi, Kentaro
    Imaoka, Yuki
    Kitamura, Yuka
    Akazawa, Yuko
    Groen, Ruben
    Nagayasu, Takeshi
    Yamasaki, Naoya
    Tuchiya, Tomoshi
    Fukuoka, Junya
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 486A - 486A
12345